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The biological relevance of Fe(II)/Fe(III) is becoming evermore apparent, especially in relation to its potential role in the progression of
neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease. The reported relationship between smoking and a reduced incidence
of neurodegenerative disorders prompted this work. In order to investigate whether nicotine can interact with iron, we have studied the
electrochemical behaviour of a Fe(II)/Fe(III) redox couple in the presence of nicotine. Solubility issues and lack of available nonreacting salts
of nicotine necessitated studies being conducted at low pH values. Cyclic voltammetry experiments revealed a definite alteration in the
electrochemical behaviour of the Fe(II)/Fe(III) redox couple suggesting the capability of nicotine to complex with free iron and, hence,
reduce its reactivity. This is evident from a slower rate of heterogeneous electron transfer, ks, and a shift from reversible to quasi-reversible
behaviour, as characterised from the diffusion coefficient (D), the full width half maximum (FWHM), DEp and Ef. Additional complexation
titrations, pH ranging from 1 to 7, confirm a weak complexation reaction occurring between Fe(III) and nicotine.
D 2004 Elsevier B.V. All rights reserved.Keywords: Nicotine; Parkinsonism; Electrochemical rate constant; Cyclic voltammetry; Formation constant1. Introduction
The neurotoxicity of free iron within the brain has been
increasingly recognised in recent years, with many studies
indicating its role in the progression of neurodegenerative
diseases [1]. Within the human brain the iron content is
highest in the substantia nigra, globus pallidus, red nucleus,
caudate nucleus and putamen [2]. Increased iron levels have
been observed in several neurological disorders. Further-
more, an excess of iron within the substantia nigra has been
linked to the progression of Parkinson’s disease through its
participation in the continuous formation of cytotoxic free
radicals [3]. In normal circumstances iron is stored/bound0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2004.05.007
Abbreviations: Ef, formal potential; Ep, peak potential; D, diffusion
coefficient cm2 s1; DEp, difference in peak-to-peak splitting; ipa, anodic
peak current; ks, apparent rate constant cm s
1; FWHM, full width half
maximum; ipc, cathodic peak current
* Corresponding author. Tel.: +43-1-58801-15350; fax: +43-1-58801-
16299.
E-mail address: wlinert@mail.zserv.tuwien.ac.at (W. Linert).up in transport proteins such as ferritin. However, any upset
in the equilibrium within the brain can result in a release of
this iron and subsequently a cataclysm of events, including
oxidative damage of vital neurotransmitters, such as dopa-
mine [4], membrane lipids, proteins and DNA [5–7]. A
well-documented example is that of paraquat toxicity of the
lung, which has been linked to the ability of paraquat to
completely release iron from ferritin [8]. Fe(III) may also
increase the inhibition of respiratory enzymes by stimulating
the nonenzymatic oxidation of 6-hydroxydopamine [9]. The
increasing awareness of the potential hazards of free tran-
sition metal ions in the body has led to attempts to find
therapeutic methods to remove these heavy metals [10].
Over the last few decades, much has been collected and
statistically analysed regarding patients at high risk of
neurodegenerative diseases. It appears that there is a signif-
icantly reduced incidence of Parkinson’s disease in cigarette
smokers [11,12]. Because of this, a number of research
laboratories are investigating the potential role of nicotine,
one of the main agents in cigarette smoke, as a therapeutic
agent [13,14]. What is even more interesting and important
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broad range of disciplines that are being used to quantify
and correlate the relationship of nicotine as a therapeutic
agent. As highlighted in a recent review [15] for a study that
is free of bias, it is essential to maintain as much consistency
between experimental designs as possible. Despite this,
there are reports suggesting that nicotine may improve
cognitive performance (especially for attentive tasks) in
patients suffering from Alzheimer’s disease [16], although
this may be a directly receptor-mediated response. A recent
review of the oxidative and antioxidative properties of
nicotine in the central nervous system, by Newman et al.
[17], concluded that, in some incidences, the production of
reactive oxygen species and lipid peroxidation may be
induced by nicotine. However, antioxidant properties were
also observed from in vivo studies using rats. Recent in vivo
work by Cormier et al. [18] showed nicotine to protect
mitochondria from the parkinsonism-inducing toxin rote-
none and suggested that one neuroprotective effect of
nicotine may be to preserve mitochondrial functions in the
central nervous system. In this context, however, it is
important to mention that decreases in the levels of the
enzyme monoamine oxidase, which result from smoking,
have also been suggested to be involved in the protective
effects [19–21] and it has also been suggested that several
components of cigarette smoke, other than nicotine, may
contribute by inhibiting that enzyme [22,23]. Furthermore,
results from in vivo studies using nicotine cannot be directly
compared with nicotine inhaled from cigarettes, as the exact
extent to which inhaled nicotine diffuses across the blood
brain barrier to the central nervous system is unknown [18].
Previous work by Linert et al. [24] examined possible
antioxidant effects of nicotine that might result from its
characteristic binding of Fe2+ and its reduction of transfer-
rin-mediated Fe uptake. These in vitro experiments
appeared to indicate a reduction of Fenton activity in the
presence of nicotine and dopamine, suggesting some anti-
oxidant properties.
Several studies of the protective and redox behaviour of
nicotine have used it as its tartrate salt, because of its ready
availability and solubility. However, results from such
studies are difficult to interpret, since tartrate is itself a
chelating agent, and for a preliminary study this would lend
an unnecessary bias that should be avoided. Interestingly
and giving the surge in epidemiological studies being
carried out to investigate the therapeutic benefit of nicotine,
there is little or no data existing in relation to the chemistry
of nicotine with Fe(II)/(III). In this study we have investi-
gated the relationship between Fe(II)/Fe(III) and nicotine by
the electrochemical technique of cyclic voltammetry. When
applied over a range of scan rates, this technique allowed the
rate of heterogeneous electron transfer, the presence of
various redox active intermediates and the overall redox
behaviour to be determined in the presence and absence of
nicotine. The main objective is to establish if there is any
reaction of nicotine with Fe(II)/(III) and to provide a goodfundamental basis for further study, while also reiterating
the use of electrochemistry to probe the underlying chemical
mechanisms of a potential therapeutic that may benefit
many. Given the limitation of this approach—studies are
restricted to low pH values as it was observed above this pH
value insoluble precipitates of iron hydroxides were formed
in the presence of nicotine in solution—pH titrations were
also carried out ranging between pH 1 and 7, to investigate
the rates of formation of any complex that may be formed
within this pH range. Previous electrochemical studies,
involving polydentate ligands and their ability to chelate
with free iron, have demonstrated that in the presence of a
known ligand there is a anodic shift in the formal potential,
while the electrochemical behaviour of the redox couple
shifts from a reversible one electron transfer reaction to a
quasi-reversible one electron transfer reaction [25]. The
results obtained in the present study are compared with
those of related work in this area [26–28] and interpreted in
terms of the possible involvement of nicotine-iron interac-
tions in the neuroprotective effects of nicotine.2. Materials and methods
2.1. Materials
Nicotine was supplied by Sigma, KCl was purchased by
Merck, FeSO47H2O from M&B. All solutions were pre-
pared with distilled water which had been deionised by a
Millipore UQ filter.
2.2. Methods
Cyclic voltammograms were obtained using a three-
electrode configuration, connected to CH Instruments elec-
trochemical work station equipped with an electrochemical
analyser (CH 660). A graphite electrode was used as an
auxillary electrode, and an Ag/AgCl reference electrode was
used, a platinum disk was used as the working electrode,
with a surface area of 0.0707 cm2. The supporting electro-
lyte was a 0.1 M KCl solution containing 5 mM FeS-
O47H2O. The working electrolyte solution was maintained
oxygen-free by bubbling nitrogen through the solution for
15 min prior to starting the experiment; throughout the
duration of the experiment the electrolytic cell was main-
tained free of oxygen by passing nitrogen over the solution.
Between each electrochemical reading the working elec-
trode was polished with 0.3 Am alpha aluminium powder
(CH Instruments). Cyclic voltammograms of 5 mM iron
solutions in the absence or presence of nicotine, varying in
concentration between 1 and 5 mM, were performed over a
wide range of scan rates. The pH of the test solution was
maintained constant, either by addition of 0.1 M NaOH or
0.1 M HCl, and was checked after each addition of nicotine.
All pH measurements were made using a Corning 240 pH
meter calibrated daily between pH 4.0, 7.0, and 10.0 at room
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known amount of a 1 M nicotine solution to 25 ml of a
standard solution of 0.05 M Fe(II) or Fe(III) ions, 0.1 M
HNO3 and 0.5 M KNO3. Addition of nicotine was from a
40- to 200-Al Gibson automatic pipette checked regularly
for accuracy according to the manufacturer’s recommenda-
tions. The nicotine acid dissociation constants were deter-
mined in the same manner as the formation constants but in
the absence of iron ions.Fig. 2. Dependence of ipa and ipc on m
1/2, between 0.02 and 0.1, for 5 mM
Fe(II)/Fe(III) at pH 2.0. Experimental conditions as in Fig. 1.3. Results
3.1. Electrochemical behaviour of nicotine in the presence
of Fe(II)/(III)
3.1.1. Behaviour at pH 2.0
Scan rate (m) studies between 0.02 and 0.5 V s1 for the
redox couple Fe(II)/(III) are shown in Fig. 1. For this
electrode reaction the Ef was 0.50 V, for all values of m,
peak-to-peak separation (DEp) was 0.068 V when m was
0.02 V s1 and steadily increased to a value of 0.206 V
when m was 0.5 V s1. Additionally, the value of full width
half maximum (FWHM) remained constant, within experi-
mental error atf 0.170F 0.01 V up to m = 0.06 V s1;
beyond this value a linear dependency was observed. This
behaviour is indicative of a Nernstian fast one-electron
transfer reaction, for a kinetically facile system [29]. Devia-
tions from the ideal response were observed, as the value of
m increased, suggesting the influence of semi-infinite diffu-
sion. In the absence of semi-infinite diffusion it would be
expected that the DEp would remain constant at 0.059 V,
assuming a switching potential at least 0.09 V beyond the
Ep. Similarly, the FWHM value should remain constant at
0.0906 V and be independent of m [29]. A plot of ipa vs. m
1/2,
Fig. 2, shows a linear dependence, characteristic of a
reversible redox behaviour. From the Randles–Sevick equa-
tion, Eq. (1), where ip is peak current, n is the number ofFig. 1. Cyclic voltammograms of 5 mM Fe(II)/Fe(III) in 0.1 M KCl
supporting electrolyte; m is 0.02, 0.04 0.06 0.08 and 0.1 V s1, from inner to
outer. Working electrode is a Pt. disk electrode (0.0707 cm2), a Ag/AgCl
reference electrode and a Pt auxillary electrode was used.electrons transferred, A is the area of the working electrode,
0.0707 cm2, C is the concentration of redox species in
solution (5 mM); it can be seen that there is a direct linear
relationship between ip and m
1/2, making it possible to
determine the rate of diffusion of the electroactive species
to and from the electrode surface. From Eq. (1), the value of
D for the Fe(II) and Fe(III) redox couple was determined to
be 1.74 103 and 1.72 103 cm2 s1, respectively.
ip ¼ 2:69 105n2=3AD1=2Cm1=2 ð1Þ
The behaviour of the Fe(II)/Fe(III) couple in the presence
of nicotine was studied, with all experimental conditions
kept constant except for the addition of varying concentra-
tions of nicotine, ranging between 1 and 5 mM. Fig. 3 shows
a series of voltammograms in the absence and presence of
varying concentrations of nicotine, where m = 0.1 V. As
shown in Fig. 3, there was a definite alteration in the overall
redox behaviour in the presence of nicotine. The oxidation
and reduction potentials both shifted, becoming more posi-
tive and negative, respectively, while the current intensity
decreased. The value of DEp broadened greatly, with a value
of 0.53 V being recorded when nicotine concentration was 5
mM. As shown in Table 1, the value of DEp was not constant,
indicating that there is a kinetic influence at all values of m.Fig. 3. Cyclic voltammograms of 5 mM Fe(II)/Fe(III) in 0.1 M KCl
electrolyte, with varying concentrations of nicotine at 1–5 mM, from outer
to inner curve, m= 0.1 V. Experimental conditions as in Fig. 1.
Table 1
Summary of the electrochemical behaviour of Fe(II)/Fe(III) couple in the presence and absence of nicotine, at pH 2.0; experimental conditions as in Figs. 1
and 3
Nicotine concentration 0 mM 1 mM 2 mM 3 mM 4 mM 5 mM
Ef 0.49 0.566 0.555 0.530 0.52 0.53
DEp 0.175 0.400 0.375 0.300 0.45 0.3
FWHM 0.074 0.1 0.1 0.097 0.111 0.102
Ipa/ipc
a 0.97 1.19 1.17 1.08 1.67 1.22
Dox ( 103 cm2 s1) 1.74 1.50 1.49 1.32 1.35 1.38
Dred ( 103 cm2 s1) 1.72 1.36 1.31 1.24 1.21 1.19
Ks forward ( 102 cm s1)b 5.9F 0.9 2.85F 0.23 2.7F 0.17 2.6F 0.19 2.84F 0.21 2.2F 0.1
Ks reverse ( 102 cm s1)b 6.2F 0.9 2.73F 0.22 2.5F 0.16 2.74F 0.21 2.7F 0.29 2.1F 0.13
a Taken when m= 0.1 V s1.
b Taken as the average value of various values of m.
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to quasi-reversible behaviour, in agreement with previous
reports [27,28]. The onset of this quasi-reversible behaviour
is clearly evident from the plot of log m vs. DEp, shown in
Fig. 4. When an electrode reaction is solely under the
influence of diffusion control, no deviation in the value of
DEp would be expected. However, as shown in Fig. 4, the
response was constant up to a log value of  1.8 in the
absence of nicotine. The steady increase that occurred
beyond this value is indicative of a kinetic influence affect-
ing the overall electrode response. The more complex
behaviour in the presence of nicotine suggests kinetic effects
to be important over the entire range.
Further confirmation of this deviation from a Nernstian
reversible one-electron transfer reaction can be obtained by
comparing the ratio of ipa/ipc, which should ideally approx-
imate to unity at all values of m. As can be seen from Table 1,
a value close to unity was obtained only in the absence of
nicotine, further indicating that in the presence of nicotine
the electrochemical behaviour of the redox couple shifts
from a reversible diffusion controlled reaction to a kineti-
cally controlled reaction [29].
Confirmation of the kinetic influence on the overall
electrochemical response was obtained by application of
the Nicholson Shain method [30], Eq. (2), where ks is the
apparent rate of electron transfer, R is the standard gasFig. 4. Plot of log m vs. DEp, at pH 2.0, (from bottom upwards) for 5 mM
Fe(II)/Fe(III) in the absence and presence of 1, 2, 3, 4, 5 mM nicotine. DO,
diffusion only; QR, quasi-reversible. Experimental conditions as in Fig. 1.constant, T is temperature, F is Faraday’s constant, D is the
rate of diffusion as determined using Eq. (1), and DEp is the
difference in value of the Epa and Epc, taken at various
values of m.
log10 ks
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RT
nFmD
r !
¼ 0:294 nF
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DEp  2:218
 1
0:0803
 0:108 nF
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DEp  2:218
 
ð2Þ
Using this equation, the value of ks for the rate of
electron transfer from the electrode to the Fe(II), at pH
2.0, was 0.059 cm s1, whereas values of 0.028 and
0.022 cm s1 were determined in the presence of 1 and 5
mM nicotine, respectively. For the reverse reaction, the rates
of electron transfer from the Fe(III) species to the electrode
surface were the same, within experimental error. The value
in the absence of nicotine was 0.062 cm s1, and those in
the presence of 1 and 5 mM nicotine were 0.027 and 0.021
cm s1 for Fe(III) alone, respectively. Such values are
indicative of a fast rate of electron transfer. The values of
ks determined according to Eq. (2) confirm a kinetic
influence on the overall electrochemical response in the
presence of nicotine. At all nicotine concentrations the rate
of electron transfer was more sluggish, an effect that may be
attributed to a shielding affect induced by complexation of
nicotine to the Fe(II)/(III) couple.
3.1.2. Behaviour at pH 3.0
The electrochemical behaviour of the redox couple in the
presence of nicotine was studied at pH 3.0, with all other
experimental conditions kept constant. Fig. 4 shows a series
of voltammograms for the Fe(II)/Fe(III) redox couple, in the
presence of varying concentrations of nicotine, where
m = 0.1 V s1.
Under these conditions, the value of Epa was 0.604 V
while that of Epc was 0.384 V (vs. Ag/AgCl). The value of
Ef is similar to what was observed for pH 2.0, i.e., 0.500 V,
Fig. 5. Plot of log10 m vs. DEp for Fe(II)/Fe(III) redox couple in the absence
and presence of nicotine, 1–5 mM in concentration.
Fig. 6. Cyclic voltammograms of 5 mM Fe(II)/Fe(III) in the presence of 0,
1, 3 and 5 mM nicotine, from outer to inner curve, using a 0.1 M KCl
supporting electrolyte, pH 3.0, m= 0.01 V s 1. Experimental conditions as
in Fig. 1.
M.H. Bridge et al. / Biochimica et Biophysica Acta 1690 (2004) 77–84 81whereas there is an increase in the value of DEp in all
instances for the Fe(II)/(III) couple in the absence of
nicotine, when compared with the results for the same
couple at pH 2.0. The plot of log m vs. DEp, shown in
Fig. 5 indicates an earlier onset of quasi-reversible behav-
iour, compared to the data in Fig. 4.
Furthermore, there is an increase in the value of FWHM
at all values of m when compared to the pH 2.0 study; these
values are summarised in Table 2. In this case the value of
FWHM was 0.084 V when m = 0.02 V s1. A plot of ipa vs.
m1/2 (not shown) gave a linear relationship, allowing the
values of D to be determined, in accordance with Eq. (1), as
1.47 103 and 1.36 103 cm2 s1 for the anodic and
cathodic reactions, respectively. Determination of ks indi-
cated that, at this pH, the rate of transfer of an electron from
the Fe(II) species to the electrode surface was more sluggish
than at pH 2.0.
The electrochemical behaviour in the presence of varying
concentrations of nicotine, 1–5 mM, m = 0.1 V s1, is also
shown in Fig. 6. As in the studies at pH 2, the value of Ef
varied upon addition of nicotine, with the largest deviation
being observed at a concentration of 5 mM. Determination of
the diffusion coefficient indicated that the rate of diffusion to
the electrode surface was much slower in the presence of
nicotine, when compared to the results obtained at pH 2.0
and also to that of the Fe(II)/(III) redox couple at pH 3.0.
Determination of ks, at this pH, in accordance with Eq. (2),Table 2
Summary of the electrochemical behaviour of Fe(II)/Fe(III) couple in the presenc
and 3
Nicotine concentration 0 mM 1 mM
Ef
a 0.500 0.580
DEp
a 0.184 0.356
FWHMa 0.101 0.137
Ipa/ipc
a 1.01 1.22
Dox ( 103 cm2 s1) 1.47 1.25
Dred ( 103 cm2 s1) 1.36 0.97
Ks forward ( 102 cm s1)a 3.78F 0.33 1.82F 0.11
Ks reverse ( 102 cm s1)b 3.6F 0.32 1.6F 0.1
a Taken when m = 0.1 V s1.
b Taken as the average value of various values of m.showed that, as in the case of the Fe (II) species, there was a
slower rate of electron transfer in the presence of nicotine.
Upon reversal of the potential sweep, a second irrevers-
ible cathodic peak, at approximately 0.1 V (vs. Ag/AgCl),
was observed at low concentrations of nicotine. The appear-
ance of a second cathodic peak can occur when the pH value
lies between two pKa values. Although it is known that the
protonation of a ligand, in this incidence nicotine
(Scheme 1), can result in a complex with a different redox
potential [31], it is more likely that this irreversible peak is
associated insoluble hydroxides as insoluble precipitates of
iron hydroxides were observed.
Increasing the concentration of nicotine beyond 2 mM
resulted in a loss of this second peak. In contrast to the
behaviour at pH 2.0, the Epred for the reduction of
Fe3+ + e! Fe2+ was similar, within an experimental error
of F 10%, for all concentrations of nicotine, 0.3 V (vs. Ag/
AgCl). Determination of D, using Eq. (2), shows that in all
instances the rate of diffusion of reduced species is slower
than for the oxidised species, as summarised in Table 2.
3.1.3. Behaviour at pH 4.0
Since the pKa values of nicotine are 3.2 and 8.0 [32], the
electrochemical behaviour at pH 4.0, which is assumed to
involve mainly the mono-protonated form of nicotine, was
also investigated. Fig. 7 shows a series of voltammograms ate and absence of nicotine, at pH 3.0; experimental conditions as in Figs. 1
2 mM 3 mM 4 mM 5 mM
0.580 0.580 0.580 0.580
0.359 0.377 0.433 0.426
0.136 0.136 0.145 0.142
1.2 1.28 1.51 1.60
1.25 1.32 1.32 1.26
0.97 0.97 0.99 0.83
1.8F 0.16 1.6F 0.09 1.65F 0.15 1.28F 0.09
2.1F 0.14 1.44F 0.087 1.43F 0.13 1.04F 0.07
Scheme 1. Molecular structures of nicotine involved in this study, pKa
is 3.2.
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nicotine. The value obtained for the oxidation of
Fe2+! Fe3+ at pH 4.0 was shifted more positively, with
respect to those observed at the lower pH values. The value
of Epox was approximately 0.627 V vs. Ag/AgCl, and the
FWHM value was 0.195, where m = 0.1 V s1. A linear
relationship between ipox and m
1/2 allowed the rate of
diffusion of electroactive species to the surface of the
working electrode to be determined as 1.5 103 cm2
s1, which is similar, within experimental error, to the
values obtained at lower pH. However, reversal of the
potential sweep resulted in reduction waves that showed a
difference in behaviour. First, the value of Epred, 0.423 V, vs.
Ag/AgCl, was shifted closer to Epox. Second, a shoulder
peak was observed at approximately 0.0 V. This may be
attributed to insoluble iron-hydroxide species that are
known to occur at this pH value in the absence of any
strong ligand species. There was an increase in the FWHM
when compared to the previous studies at lower pH values.
Furthermore, a plot of ipa vs. m
1/2 was linear, allowing the
diffusion coefficients to be determined as 1.36 103 and
1.49 103 cm2 s1. This decrease in the rate of diffusion
of electroactive species to the electrode surface, when
compared with the value of Dox at this pH, is in agreement
with the study conducted at pH 3.0, which showed the rate
of diffusion of Fe2+ to the electroactive surface to be more
facile than the rate of diffusion of the Fe3+ species.
Addition of nicotine caused a similar shift in the Epox,
0.73 V vs. Ag/AgCl in a more positive direction. However,Fig. 7. Cyclic voltammograms of 5 mM Fe(II)/Fe(III) in 0.1 M KCl
supporting electrolyte, pH 4.0, in the presence and absence of nicotine, 1, 3,
5 mM in concentration; m is 0 0.1 V s1, from inner to outer. Working
electrode is a Pt. disk electrode (0.0707 cm1); a Ag/AgCl reference
electrode and a Pt auxillary electrode were used.in contrast to the results at lower pH values, there were no
discrepancies between the different nicotine concentrations.
Plotting ipox vs. m
1/2 also gave a linear relationship. As was
observed as in the studies at the pH 3.0 study, there was a
trend where the presence of nicotine resulted in the rate of
diffusion to the electrode surface being more sluggish,
when compared with the Fe(II) response in the absence of
nicotine and the onset of quasi-reversible behaviour at an
earlier scan rate. For electrolyte solutions containing nic-
otine concentrations ranging between 1 and 4 mM, the
corresponding reduction peak was at 0.34 V, vs. Ag/AgCl,
similar to the values obtained at the lower pH values. With
increasing concentrations of nicotine the ipred decreased,
and no significant reverse peak could be detected in the
presence of 5 mM nicotine. At that nicotine concentration
study a peak appeared at approximately 0 V. A second
irreversible cathodic peak was seen in the region of 0.1 V,
for nicotine concentrations between 1 and 4 mM, similar to
that observed at pH 3.0 in the presence of 1 and 2 mM
nicotine.
Thus, the behaviour of the Fe(II)/Fe(III) couple is more
representative of a quasi-irreversible redox couple at pH 4.0.
This was confirmed from the plot of log10 m vs. DEp (not
shown), which showed that, even at slow values of m, the
Fe(II)/Fe(III) couple has no electrochemical behaviour rem-
iniscent of a reversible redox couple, i.e., dependence of Ef
on m. Determination of the rates of heterogeneous electron
transfer for the Fe(II)/Fe(III) couple showed these to be,
again, more sluggish for both the forward and reverse
reactions. These data are summarised in Table 3.
3.2. Complexation titrations
To confirm the initial suspicion of a complex being
formed, pH titrations using nicotine and Fe(II)/(III) salt
were performed. Again, nicotine, as opposed to its tartrate,
was used where possible to avoid any unnecessary experi-
mental bias. Initial results enabled approximate values for
K1 and K2 of 1.82 108 and 5.1103, respectively, to be
determined where K1 and K2 are the binding constants for a
first and second nicotine to Fe(III). Complexation appears to
occur regardless of the protonation state of the nicotine,
which suggests that the complex formed is not a chelate.
However, further work is required to isolate and characterise
the complex formed.4. Discussion
This study was prompted by the increase in epidemio-
logical studies suggesting the potential therapeutic value of
nicotine. The toxicity of excessive free iron and its potential
role in neurodegenerative diseases have been well docu-
mented, but there is a lack of fundamental chemical infor-
mation dealing with the kinetics of the interactions between
nicotine and Fe(II)/(III).
Table 3
Summary of the electrochemical behaviour of Fe(II)/Fe(III) couple in the presence and absence of nicotine, at pH 4.0; experimental conditions as in Figs. 1
and 3
Nicotine concentration 0 mM 1 mM 2 mM 3 mM 4 mM 5 mM
Ef
a 0.53 0.580 0.580 0.580 0.580 0.580
DEp
a 0.218 0.400 0.441 0.465 0.428 –
FWHMa 0.195 0.215 0.225 0.217 0.240 0.265
Ipa/ipc
a 1.01 1.22 1.2 1.28 1.51 1.60
Dox ( 103 cm2 s1) 1.49 1.25 1.25 1.32 1.32 1.26
Dred ( 103 cm2 s1) 1.36 0.97 0.97 0.97 0.99 0.83
Ks forward ( 102 cm s1)a 3.5F 0.1 1.1F 0.09 0.9F 0.08 1.2F 0.09 0.9F 0.08 –
Ks reverse ( 102 cm s1)b 3.3F 0.15 0.9F 0.08 0.8F 0.087 1.0F 0.09 0.85F 0.075 –
a Taken when m = 0.1 V s1.
b Taken as the average value of various values of m.
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ability of various polydentate ligands to bind to free metals
in solution, have shown the electrochemical behaviour of
metal–ligand complexes to be pH-dependant. For example,
El-Jammal and Templeton [27,28], who studied the electro-
chemical behaviour of 3-hydroxypyridin-4-one iron chela-
tors between a pH range of 3.7 and 10, corresponding to the
range of its pKa values of 3.84 and 9.86, showed the
oxidation peak associated with Fe(III) species to shift in a
positive direction upon complexation of iron to 3-hydrox-
ypyridin-4-one while the current intensity decreased. For the
reverse scan, these workers reported a shift in the reduction
peak to more negative values. As a consequence of this
altered redox behaviour, the value for peak-to-peak splitting
(DEp) and FWHM were much larger, whereas the current
ratio of ipa/ipc deviated from the value of close to unity that
would be expected for a fast one-electron transfer reaction.
Shifts in redox peak values in the presence of known
chelators or ligands of iron in solution, which are qualita-
tively similar to those observed in the present work, have
been reported in several previous studies, such as those of
Maharaj et al. [33], who investigated the redox behaviour of
free iron in the presence and absence of 6-hydroxymelatonin
at pH 7.3. de Abreu et al. [34], who studied the electro-
chemical behaviour of Fe(II)/Fe(III) in the presence and
absence of 2-nitronaphthiophen-4,9-quinone, attributed the
shift in Ep to a fast chemical reaction, coupled to a
heterogeneous reversible process, and postulated that the
catalytic mechanism was related to the reaction of the
nitrogen to its anionic radical that subsequently complexed
with Fe. The effects of alterations in ligand concentration
have been studied using EDTA [35] and it was found that
increasing the ligand/metal ratio resulted in a decrease in the
slopes of the plot of ip vs. m
1/2, similar to those reported in
the present work (see Tables 1–3). Those results were
interpreted in terms of the resultant current being controlled
by semi-infinite diffusion to the electrode surface.
In all reported instances, it was concluded that in the
presence of a ligand the electrochemical behaviour of the
redox species shifted from a reversible electrode reaction to a
quasi-irreversible electrode reaction. However, with the ex-
ception of the studies with 6-hydroxymelatonin [24], a knownscavenger of iron within the body, these studies have used
unphysiological compounds. Nicotine is of potential physio-
logical interest in view of the reported protective effects of
smoking against Parkinson’s disease [7,11] and the postulated
involvement of iron-generated reactive oxygen species in the
etiology of that disease (see, e.g. Refs. [2–4]). Unfortunately,
a limitation of the electrochemical approach, in this incidence,
in the absence of stabilizing ligands is that it cannot be applied
at physiological pH values because of the insolubility of
Fe(II)/Fe(III) above pH 4.0. Nicotine itself has poor solubility
at neutral pH values, a problem that has been circumvented in
some studies by using its more soluble tartrate salt. Unfortu-
nately, as already stated, it was not possible to carry out this
electrochemical study at any pH corresponding to either the
brain under normal conditions (pH 7.2) or inflammatory (pH
5.5) conditions. To date, most studies involving the chemical
interaction of Fe(II)/Fe(III) with nicotine use its tartrate salt.
However, effects of nicotine tartrate on the redox behaviour of
iron are of doubtful validity because tartaric acid binds to iron
much more tightly than nicotine. This higher affinity of
tartrate for iron would make it difficult to correct for its
effects by comparing the behaviour of tartrate with that of free
tartrate. Thus, the nicotine tartrate salt was not used in the
present work. Studies involving pH titrations are consistent
with the formation of a weak complex with Fe(III). Although
further studies using different experimental protocols will be
necessary to see whether the behaviour reported here may be
extrapolated to themore complex conditions and higher pH of
the physiological environment, the important conclusion
from the present work, that nicotine considerably reduces
the rates of oxidation/reduction for the Fe(II)/Fe(III) redox
couple, might suggest it to be capable of slowing down many
of reactions associated with the progression of neurodegen-
erative diseases.Acknowledgements
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